TY - JOUR
T1 - Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening
AU - Jin, Wei
AU - Deng, Yexuan
AU - La Marca, John E.
AU - Lelliott, Emily J.
AU - Diepstraten, Sarah T.
AU - König, Christina
AU - Tai, Lin
AU - Snetkova, Valentina
AU - Dorighi, Kristel M.
AU - Hoberecht, Luke
AU - Hedditch, Millicent G.
AU - Whelan, Lauren
AU - Healey, Geraldine
AU - Fayle, Dan
AU - Lau, Kieran
AU - Potts, Margaret A.
AU - Chen, Moore Z.
AU - Johnston, Angus P.R.
AU - Liao, Yang
AU - Shi, Wei
AU - Kueh, Andrew J.
AU - Haley, Benjamin
AU - Fortin, Jean Philippe
AU - Herold, Marco J.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/1/30
Y1 - 2025/1/30
N2 - Cas12a is a next-generation gene editing tool that enables multiplexed gene targeting. Here, we present a mouse model that constitutively expresses enhanced Acidaminococcus sp. Cas12a (enAsCas12a) linked to an mCherry fluorescent reporter. We demonstrate efficient single and multiplexed gene editing in vitro, using primary and transformed cells from enAsCas12a mice. We further demonstrate successful in vivo gene editing, using normal and cancer-prone enAsCas12a stem cells to reconstitute the haematopoietic system of wild-type mice. We also present compact, genome-wide Cas12a knockout libraries, with four crRNAs per gene encoded across one (Scherzo) or two (Menuetto) vectors, and demonstrate the utility of these libraries across methodologies: in vitro enrichment and drop-out screening in lymphoma cells and immortalised fibroblasts, respectively, and in vivo screens to identify lymphoma-driving events. Finally, we demonstrate CRISPR multiplexing via simultaneous gene knockout (via Cas12a) and activation (via dCas9-SAM) using primary T cells and fibroblasts. Our enAsCas12a mouse and accompanying crRNA libraries enhance genome engineering capabilities and complement current CRISPR technologies.
AB - Cas12a is a next-generation gene editing tool that enables multiplexed gene targeting. Here, we present a mouse model that constitutively expresses enhanced Acidaminococcus sp. Cas12a (enAsCas12a) linked to an mCherry fluorescent reporter. We demonstrate efficient single and multiplexed gene editing in vitro, using primary and transformed cells from enAsCas12a mice. We further demonstrate successful in vivo gene editing, using normal and cancer-prone enAsCas12a stem cells to reconstitute the haematopoietic system of wild-type mice. We also present compact, genome-wide Cas12a knockout libraries, with four crRNAs per gene encoded across one (Scherzo) or two (Menuetto) vectors, and demonstrate the utility of these libraries across methodologies: in vitro enrichment and drop-out screening in lymphoma cells and immortalised fibroblasts, respectively, and in vivo screens to identify lymphoma-driving events. Finally, we demonstrate CRISPR multiplexing via simultaneous gene knockout (via Cas12a) and activation (via dCas9-SAM) using primary T cells and fibroblasts. Our enAsCas12a mouse and accompanying crRNA libraries enhance genome engineering capabilities and complement current CRISPR technologies.
UR - http://www.scopus.com/inward/record.url?scp=85217357665&partnerID=8YFLogxK
U2 - 10.1038/s41467-025-56282-2
DO - 10.1038/s41467-025-56282-2
M3 - Article
C2 - 39885149
AN - SCOPUS:85217357665
SN - 2041-1723
VL - 16
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 974
ER -